N

National Taiwan University Hospital | Department of Internal Medicine, Division of Gastroenterology

Research site

(Unclaimed)

Location

Number 8, Zhongshan South Road 16F Children Medical Building, Taipei City, Taipei, Taiwan

Site insights

Top conditions

Top treatments

Budigalimab

Livmoniplimab

Parent organization

This site is a part of National Taiwan University Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC) (LIVIGNO-2)

Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presentin...

Enrolling

Hepatocellular Carcinoma

Drug: Budigalimab

Drug: Durvalumab

Trial sponsors

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms